Nova Iguaçu
Nova Iguaçu
Nova Iguaçu, Rio de Janeiro, Brazil5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women | HIV-1-infection | Recruiting | Phase 4 | 2026-09-18 | NCT07616739 | |
| A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 3 | 2026-09-18 | NCT07044297 | |
| DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection | HIV-1-infection | Recruiting | Phase 3 | 2026-07-27 | NCT06203132 | |
| Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not applicable | 2026-05-13 | NCT07584122 | |
| ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention | Contact With or Exposure to Human Immunodeficiency Virus | Recruiting | Not applicable | 2026-03-27 | NCT07497594 |